
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT is supported by a strong external growth engine, as it has repeatedly outperformed on normalized FFO and FAD while raising FY26 guidance to $2.08–$2.09 and $2.04–$2.05, respectively. Its $2.9B YTD investment pace at an 8.1% stabilized yield, plus a $1.2B actionable pipeline and recent equity and debt financing, point to ample capital to keep compounding cash flow. The outlook is further strengthened by low leverage, with reported net debt to annualized adjusted EBITDA of 1.4x, resilient triple-net lease economics, and a maintained $0.39 quarterly dividend with a 74.1% 3Q26 payout ratio.
Bears say
CareTrust REIT is exposed to a weak risk/reward setup because its earnings depend on careful acquisition underwriting in a highly regulated skilled nursing market where reimbursement, licensure, and labor conditions can quickly pressure operator cash flow and property NOI. The company also faces elevated tenant concentration risk, with Ensign representing a significant share of NOI and carrying lingering compliance overhang from the October 2013 corporate integrity agreement, while headline risk from PACS could still re-emerge. At the same time, competition for healthcare assets may inflate purchase prices and tighter debt or capital markets could constrain leverage-funded growth, undermining profitability and valuation.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About CareTrust REIT (CTRE) Forecast
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares